Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety.

Simona LattanziFrancesco BrigoEugen TrinkaGaetano ZaccaraPasquale StrianoCinzia Del GiovaneMauro Silvestrini

Published in: CNS drugs (2021)

Adjunctive CBD resulted in a greater reduction in convulsive seizure frequency than placebo and a higher rate of AEs in patients with DS presenting with seizures uncontrolled by concomitant antiepileptic therapy.

Keyphrases

case report
temporal lobe epilepsy
double blind
stem cells
cell therapy
placebo controlled